Characteristics of ATL patients receiving allogeneic HSCT
| Characteristic . | MAC . | RIC . | P . |
|---|---|---|---|
| Total patients, no. (%) | 280 | 306 | |
| Age range at transplantation, y | < .001 | ||
| 15-55 | 248 (89) | 124 (41) | |
| 56-72 | 32 (11) | 182 (59) | |
| Sex | .135 | ||
| Female | 120 (43) | 151 (49) | |
| Male | 160 (57) | 155 (51) | |
| Disease status at transplantation | .206 | ||
| CR | 96 (34) | 112 (37) | |
| Non-CR | 160 (57) | 179 (58) | |
| Unknown | 24 (9) | 15 (5) | |
| Year.month of transplantation | .473 | ||
| 1992.2-2004.12 | 71 (25) | 78 (25) | |
| 2005.1-2006.11 | 69 (25) | 77 (25) | |
| 2006.11-2008.5 | 76 (27) | 68 (22) | |
| 2008.5-2009.12 | 64 (23) | 83 (27) | |
| Time from diagnosis to transplantation, mo | .569 | ||
| 0.5-4.9 | 74 (26) | 72 (24) | |
| 4.9-6.9 | 66 (24) | 79 (26) | |
| 6.9-10.1 | 74 (26) | 71 (23) | |
| ≥10.1 | 65 (23) | 81 (26) | |
| PS at transplantation | .004 | ||
| 0 | 102 (36) | 119 (39) | |
| 1 | 121 (43) | 143 (47) | |
| 2 | 29 (10) | 25 (8) | |
| 3 | 4 (1) | 12 (4) | |
| 4 | 3 (1) | 2 (1) | |
| Unknown | 21 (8) | 5 (2) | |
| Source of stem cells | < .001 | ||
| BM | 212 (76) | 186 (60) | |
| Peripheral blood | 68 (24) | 118 (39) | |
| BM + peripheral blood | 0 (0) | 2 (1) | |
| Relationship between recipient and donor | .019 | ||
| HLA-matched related | 96 (34) | 117 (38) | |
| HLA-mismatched related | 21 (8) | 42 (14) | |
| HLA-unknown related | 1 (0) | 1 (0) | |
| Unrelated | 162 (58) | 146 (48) | |
| ATL clinical subtype | .253 | ||
| Chronic, smoldering | 10 (4) | 6 (2) | |
| Acute | 163 (58) | 170 (56) | |
| Lymphoma | 79 (28) | 87 (28) | |
| Unknown | 28 (10) | 43 (14) |
| Characteristic . | MAC . | RIC . | P . |
|---|---|---|---|
| Total patients, no. (%) | 280 | 306 | |
| Age range at transplantation, y | < .001 | ||
| 15-55 | 248 (89) | 124 (41) | |
| 56-72 | 32 (11) | 182 (59) | |
| Sex | .135 | ||
| Female | 120 (43) | 151 (49) | |
| Male | 160 (57) | 155 (51) | |
| Disease status at transplantation | .206 | ||
| CR | 96 (34) | 112 (37) | |
| Non-CR | 160 (57) | 179 (58) | |
| Unknown | 24 (9) | 15 (5) | |
| Year.month of transplantation | .473 | ||
| 1992.2-2004.12 | 71 (25) | 78 (25) | |
| 2005.1-2006.11 | 69 (25) | 77 (25) | |
| 2006.11-2008.5 | 76 (27) | 68 (22) | |
| 2008.5-2009.12 | 64 (23) | 83 (27) | |
| Time from diagnosis to transplantation, mo | .569 | ||
| 0.5-4.9 | 74 (26) | 72 (24) | |
| 4.9-6.9 | 66 (24) | 79 (26) | |
| 6.9-10.1 | 74 (26) | 71 (23) | |
| ≥10.1 | 65 (23) | 81 (26) | |
| PS at transplantation | .004 | ||
| 0 | 102 (36) | 119 (39) | |
| 1 | 121 (43) | 143 (47) | |
| 2 | 29 (10) | 25 (8) | |
| 3 | 4 (1) | 12 (4) | |
| 4 | 3 (1) | 2 (1) | |
| Unknown | 21 (8) | 5 (2) | |
| Source of stem cells | < .001 | ||
| BM | 212 (76) | 186 (60) | |
| Peripheral blood | 68 (24) | 118 (39) | |
| BM + peripheral blood | 0 (0) | 2 (1) | |
| Relationship between recipient and donor | .019 | ||
| HLA-matched related | 96 (34) | 117 (38) | |
| HLA-mismatched related | 21 (8) | 42 (14) | |
| HLA-unknown related | 1 (0) | 1 (0) | |
| Unrelated | 162 (58) | 146 (48) | |
| ATL clinical subtype | .253 | ||
| Chronic, smoldering | 10 (4) | 6 (2) | |
| Acute | 163 (58) | 170 (56) | |
| Lymphoma | 79 (28) | 87 (28) | |
| Unknown | 28 (10) | 43 (14) |